Technical Analysis for ARGS - Argos Therapeutics

Grade Last Price % Change Price Change
grade D 0.1 0.00% 0.0000
ARGS closed unchanged on Tuesday, December 4, 2018, on 1.25 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical ARGS trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Volume Surge Other 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%

Older signals for ARGS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Argos Therapeutics, Inc., an immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on its proprietary technology platform, Arcelis. Its product candidates include rocapuldencel-T, which is in Phase III clinical trial for the treatment of metastatic renal cell carcinoma. The company also develops AGS-004, which is in Phase II clinical trials for the treatment of human immunodeficiency virus. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is based in Durham, North Carolina.
Medicine Cancer Infectious Diseases Health Care Treatment Of Cancer Cancer Immunotherapy Immunotherapies Ags 004 Arcelis Immunotherapies Based On Its Proprietary Technology Metastatic Renal Cell Carcinoma
Is ARGS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.25
52 Week Low 0.07
Average Volume 54,029
200-Day Moving Average 0.0
50-Day Moving Average 0.1375
20-Day Moving Average 0.125
10-Day Moving Average 0.1166
Average True Range 0.0237
ADX 14.49
+DI 13.8503
-DI 24.8944
Chandelier Exit (Long, 3 ATRs ) 0.0789
Chandelier Exit (Short, 3 ATRs ) 0.14110000000000001
Upper Bollinger Band 0.1534
Lower Bollinger Band 0.0966
Percent B (%b) 0.06
BandWidth 45.44
MACD Line -0.0096
MACD Signal Line -0.0061
MACD Histogram -0.0035
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1225
Resistance 3 (R3) 0.1233 0.1167 0.1188
Resistance 2 (R2) 0.1167 0.1109 0.1163 0.1175
Resistance 1 (R1) 0.1083 0.1074 0.1075 0.1075 0.1162
Pivot Point 0.1017 0.1017 0.1013 0.1013 0.1017
Support 1 (S1) 0.0933 0.0959 0.0925 0.0925 0.0838
Support 2 (S2) 0.0867 0.0924 0.0863 0.0825
Support 3 (S3) 0.0783 0.0867 0.0813
Support 4 (S4) 0.0775